Clinical and economic burden of infused iron chelation therapy in the United States von Payne, Krista A., Desrosiers, Marie-Pierre, Caro, J. Jaime, Baladi, Jean-François, Lordan, Noreen, Proskorovsky, Irina, Ishak, Khajak, Rofail, Diana

Volltext

Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload von Payne, Krista A., Rofail, Diana, Baladi, Jean-François, Viala, Muriel, Abetz, Linda, Desrosiers, Marie-Pierre, Lordan, Noreen, Ishak, Khajak, Proskorovsky, Irina

Volltext

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review von Delea, Thomas E., Edelsberg, John, Sofrygin, Oleg, Thomas, Simu K., Baladi, Jean-Francois, Phatak, Pradyumna D., Coates, Thomas D.

Volltext

The impact of iron overload and its treatment on quality of life: results from a literature review von Abetz, Linda, Baladi, Jean-Francois, Jones, Paula, Rofail, Diana

Volltext

Use of economic evaluation guidelines: 2 years' experience in Canada von Baladi, Jean-François, Menon, Devidas, Otten, Nicolaas

Volltext

Satisfaction and Adherence in Patients with Iron Overload Receiving Iron Chelation Therapy as Assessed by a Newly Developed Patient Instrument von Rofail, Diana, MSc, Abetz, Linda, MA, Viala, Muriel, MSc, Gait, Claire, MPhil, Baladi, Jean-Francois, MBA, Payne, Krista, MEd

Volltext

Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia von Cappellini, Maria Domenica, MD, Bejaoui, Mohamed, MD, Agaoglu, Leyla, MD, Porter, John, MD, Coates, Thomas, MD, Jeng, Michael, MD, Lai, Maria Eliana, MD, Mangiagli, Antonio, MD, Strauss, Gabriele, MD, Girot, Robert, MD, Watman, Nora, MD, Ferster, Alina, MD, Loggetto, Sandra, MD, Abish, Sharon, MD, Cario, Holger, MD, Zoumbos, Nicolaos, MD, Vichinsky, Elliott, MD, Opitz, Herbert, MD, Ressayre-Djaffer, Catherine, PhD, Abetz, Linda, MA, Rofail, Diana, MSc, Baladi, Jean-Francois, MBA

Volltext

Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib von Casciano, Roman, MS, Chulikavit, Maruit, MPH, Di Lorenzo, Giuseppe, MD, PhD, Liu, Zhimei, PhD, Baladi, Jean-Francois, MBA, Wang, Xufang, MBA, MD, Robertson, Justin, MA, Garrison, Lou, PhD

Volltext

Biases in cost measurement for economic evaluation studies in health care von Jacobs, Philip, Baladi, Jean-François

Volltext

Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States von Delea, Thomas E., Hagiwara, May, Thomas, Simu K., Baladi, Jean‐Francois, Phatak, Pradyumna D., Coates, Thomas D.

Volltext

Satisfaction and Adherence Significantly Improves in Patients with β-Thalassemia and Myelodysplastic Syndromes Treated with Deferasirox (Exjade®) von Porter, John B, Bowden, Donald, Ganser, Arnold, Domokos, Gabor, Rofail, Diana, Baladi, Jean-François, Cappellini, Maria Domenica

Volltext

Improved Health-Related Quality of Life in Patients with Hematological Disorders Receiving Deferasirox (Exjade®) von Porter, John B, Bowden, Donald, Ganser, Arnold, Domokos, Gabor, Gater, Adam, Baladi, Jean-François, Cappellini, Maria Domenica

Volltext

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade®) in β-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies... von Porter, John B., Athanasiou-Metaxa, Miranda, Bowden, Donald K., Troncy, Jacques, Habr, Dany, Domokos, Gabor, Roubert, Bernard, Rofail, Diana, Gater, Adam, Baladi, Jean-François, Cappellini, M. Domenica

Volltext

Treatment interruptions and non-adherence with imatinib and associated healthcare costs : A retrospective analysis among managed care patients with chronic myelogenous leukaemia von DARKOW, Theodore, HENK, Henry J, THOMAS, Simu K, WEIWEI FENG, BAIADI, Jean-Francois, GOLDBERG, George A, HATFIELD, Alan, CORTES, Jorge

Volltext

Rivastigmine for alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications von Baladi, Jean-François, Bailey, Peter A.B., Black, Sandra, Bouchard, Rémi W., Farcnik, Karl D., Gauthier, Serge, Kertesz, Andrew, Mohr, Erich, Robillard, Alain

Volltext

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients : US healthcare system perspe... von DELEA, Thomas E, SOFRYGIN, Oleg, THOMAS, Simu K, BALADI, Jean-Francois, PHATAK, Pradyumna D, COATES, Thomas D

Volltext

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial von Taher, Ali, Al Jefri, Abdullah, Elalfy, Mohsen Saleh, Al Zir, Kusai, Daar, Shahina, Rofail, Diana, Baladi, Jean François, Habr, Dany, Kriemler-Krahn, Ulrike, El-Beshlawy, Amal

Volltext

A comparative review of pharmacoeconomic guidelines von Jacobs, P, Bachynsky, J, Baladi, J F

Volltext

An instrument assessing satisfaction with iron chelation therapy: Psychometric testing from an open-label clinical trial von Rofail, Diana, Viala, Muriel, Gater, Adam, Abetz-Webb, Linda, Baladi, Jean-Francois, Cappellini, Maria Domenica

Volltext

Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label... von Vichinsky, Elliott, Pakbaz, Zahra, Onyekwere, Onyinye, Porter, John, Swerdlow, Paul, Coates, Thomas, Lane, Peter, Files, Beatrice, Mueller, Brigitta U, Coïc, Lena, Forni, Gian Luca, Fischer, Roland, Marks, Peter, Rofail, Diana, Abetz, Linda, Baladi, Jean-Francois

Volltext